In a recent preclinical study, the intranasal administration of hyperforin was able to improve post-stroke social isolation-induced exaggeration of post-stroke depression and anxiety and promoted hippocampal neurogenesis and cognitive function by rescuing TGF-β1 levels [79]. This evidence concerns the gene TGFB1 and major depressive disorder.